Filing Flows

Filing Flows › Immunocore Holdings (IMCR) › Next earnings date

Immunocore Holdings (IMCR) earnings: missed the estimate

Immunocore Holdings (IMCR) reported on Nov 6, 2026 and missed the EPS estimate: −$0.28 against −$0.14 (-107.3%). Revenue was $102M for Q3 2026, -1% year over year. It beat the EPS estimate in 40% of the quarters on record.

Last result−107.3% vs estimate
Beat rate40%

The last report

Immunocore Holdings reported revenue of $102M for the third quarter 2026 (-1% Y/Y), net loss $14.2M. How it makes money → · Every quarter →

Immunocore Holdings: EPS against the estimate, last 5 reportsImmunocore Holdings: EPS against the estimate, last 5 reportsEstimateReported−$0.24$0.00Nov 25−$0.20−$0.60Feb 26−$0.26$0.25May 26$0.02−$0.02Aug 26−$0.14−$0.28Nov 26
Latest (Nov 26): Estimate −$0.14, Reported −$0.28.
IMCR: the stock's move on each reportIMCR: the stock's move on each reportAug 6, 2026+2.1%May 6, 2026+6.2%Feb 25, 2026-4.9%Nov 6, 2025+8.8%

Immunocore Holdings' latest quarter

Immunocore Holdings, Q3 2026: revenue $102M (-1% year over year), operating margin -13.3%, net loss $14.2M, operating cash flow $20.1M. The chart follows the revenue to costs, profit and cash.

Questions

Did Immunocore Holdings beat earnings?

Immunocore Holdings (IMCR) reported on Nov 6, 2026 and missed the EPS estimate: −$0.28 against −$0.14 (-107.3%).

When does IMCR report earnings?

The next date is not set yet.

Does Immunocore Holdings usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.